CAN FITE BIOPHARMA LTD (CANF)
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
Second Quarter 2026 Resultsate Report
Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
PPHC Acquires Florida Government Relations Firm
VisionWave Files International Trademark Application for STRATUM™ AI Platform
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
BCB Bancorp, Inc. Reports Net Loss of $14.8 Million in the Second Quarter 2026; Board Approves Reincorporation in Delaware, Subject to Shareholder Approval
Luckin Coffee Announces Second Quarter 2026 Financial Results
Sportradar Reports Second Quarter 2026 Financial Results
EVA LIVE INC. ANNOUNCES FORMATION OF EVA DEFENSE ADVISORY BOARD, APPOINTS GENERAL ROBERT BROOKS BROWN (R) AND ROSS MANDEL